Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixivaptan for Hyponatremia in Heart Failure (THE BALANCE Study)
NCT00578695Phase 3Completed
- Sponsor
- CardioKine
- Start
- Jan 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 3, randomised, double-blind trial in hyponatremia comparing Lixivaptan Arm with Placebo Arm (2 arms). Primary endpoint: Change in serum sodium from baseline at 60 days. Started Jan 2007; status: completed.
02
Drugs
lixivaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00578695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578695.